Literature DB >> 21334078

S100A8/A9 complex as a new biomarker in prediction of mortality in elderly patients with severe heart failure.

Li-Ping Ma1, Espen Haugen, Masaki Ikemoto, Masatoshi Fujita, Fumio Terasaki, Michael Fu.   

Abstract

BACKGROUND: S100A8/A9 complex is a new inflammation-related protein and has a positive correlation with C-reaction protein level. However its role in chronic heart failure (CHF) remains unclear. METHODS AND
RESULTS: Circulating levels of S100A8/A9 complex and other biomarkers (IL-6, IL-8, TNF-α, and BNP) were measured in CHF (n = 54) and hypertensive without CHF (n = 31) as well as healthy subjects (n = 23), with follow up to 1480 days. During follow-up, cumulative mortality rate for CHF patients was 63%. Plasma levels of S100A8/A9 complex, IL-6, IL-8 and TNF-α were significantly higher in CHF than the hypertensive patients and healthy subjects. A significant positive correlation was found between S100A8/A9 complex and IL-6 and IL-8 respectively. Cox regression analysis showed that IL-6 and IL-8 were predictors for mortality for 6 months, and S100A8/A9 complex, IL-6, IL-8 and age were predictors for mortality for one year whereas BNP, TNF-α, IL-6 and IL-8 remained predictors for mortality for two years. A combination of S100A8/A9 complex and IL-6 provided powerful predictive value in mortality for both 6 and 12 months.
CONCLUSIONS: S100A8/A9 complex is a useful biomarker as a predictor for one year mortality and its combination with IL-6 is able to provide additive prognostic information in this vulnerable heart failure population in the elderly.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21334078     DOI: 10.1016/j.ijcard.2011.01.082

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  16 in total

1.  β-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares.

Authors:  Emily L Goldberg; Jennifer L Asher; Ryan D Molony; Albert C Shaw; Caroline J Zeiss; Chao Wang; Ludmilla A Morozova-Roche; Raimund I Herzog; Akiko Iwasaki; Vishwa Deep Dixit
Journal:  Cell Rep       Date:  2017-02-28       Impact factor: 9.423

Review 2.  Clinical adoption of prognostic biomarkers: the case for heart failure.

Authors:  Andreas P Kalogeropoulos; Vasiliki V Georgiopoulou; Javed Butler
Journal:  Prog Cardiovasc Dis       Date:  2012 Jul-Aug       Impact factor: 8.194

3.  Target-selective protein S-nitrosylation by sequence motif recognition.

Authors:  Jie Jia; Abul Arif; Fulvia Terenzi; Belinda Willard; Edward F Plow; Stanley L Hazen; Paul L Fox
Journal:  Cell       Date:  2014-10-16       Impact factor: 41.582

Review 4.  Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review.

Authors:  Egidio Imbalzano; Giuseppe Mandraffino; Marco Casciaro; Sebastiano Quartuccio; Antonino Saitta; Sebastiano Gangemi
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

5.  Targeting OCT3 attenuates doxorubicin-induced cardiac injury.

Authors:  Kevin M Huang; Megan Zavorka Thomas; Tarek Magdy; Eric D Eisenmann; Muhammad Erfan Uddin; Duncan F DiGiacomo; Alexander Pan; Markus Keiser; Marcus Otter; Sherry H Xia; Yang Li; Yan Jin; Qiang Fu; Alice A Gibson; Ingrid M Bonilla; Cynthia A Carnes; Kara N Corps; Vincenzo Coppola; Sakima A Smith; Daniel Addison; Anne T Nies; Ralf Bundschuh; Taosheng Chen; Maryam B Lustberg; Joanne Wang; Stefan Oswald; Moray J Campbell; Pearlly S Yan; Sharyn D Baker; Shuiying Hu; Paul W Burridge; Alex Sparreboom
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

Review 6.  S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease.

Authors:  Alexandru Schiopu; Ovidiu S Cotoi
Journal:  Mediators Inflamm       Date:  2013-12-22       Impact factor: 4.711

7.  Natural Compound from Olive Oil Inhibits S100A9 Amyloid Formation and Cytotoxicity: Implications for Preventing Alzheimer's Disease.

Authors:  Manuela Leri; Himanshu Chaudhary; Igor A Iashchishyn; Jonathan Pansieri; Željko M Svedružić; Silvia Gómez Alcalde; Greta Musteikyte; Vytautas Smirnovas; Massimo Stefani; Monica Bucciantini; Ludmilla A Morozova-Roche
Journal:  ACS Chem Neurosci       Date:  2021-05-12       Impact factor: 4.418

8.  Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction.

Authors:  Roseanne Raphael; Diana Purushotham; Courtney Gastonguay; Marla A Chesnik; Wai-Meng Kwok; Hsiang-En Wu; Sanjiv J Shah; Shama P Mirza; Jennifer L Strande
Journal:  J Transl Med       Date:  2016-01-20       Impact factor: 5.531

9.  S100A8 and S100A9 Are Associated with Doxorubicin-Induced Cardiotoxicity in the Heart of Diabetic Mice.

Authors:  Xiao M Pei; Bjorn T Tam; Thomas K Sin; Feng F Wang; Benjamin Y Yung; Lawrence W Chan; Cesar S Wong; Michael Ying; Christopher W Lai; Parco M Siu
Journal:  Front Physiol       Date:  2016-08-05       Impact factor: 4.566

10.  Urinary Biomarkers Improve the Diagnosis of Intrinsic Acute Kidney Injury in Coronary Care Units.

Authors:  Chih-Hsiang Chang; Chia-Hung Yang; Huang-Yu Yang; Tien-Hsing Chen; Chan-Yu Lin; Su-Wei Chang; Yi-Ting Chen; Cheng-Chieh Hung; Ji-Tseng Fang; Chih-Wei Yang; Yung-Chang Chen
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.